Achieving Hierarchical Selective Ablation and Remodeling “Cold” Tumors via a Dual‐Organelle‐Targeted AIE Nanoplatform: Synergizing Ferroptosis, ICD, and cGAS–STING Activation
Immunotherapy has created new opportunities for treating triple‐negative breast cancer (TNBC), but its benefit is often limited by an immunosuppressive tumor microenvironment. Here, we report BMFL, a folate receptor‐targeted liposomal nanoplatform that co‐delivers a near‐infrared aggregation‐induced emission luminogens...